Work

Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat

Year: 2002

Type: article

Source: Brain Research

DOI: 10.1016/s0006-8993(02)03189-x

Authors: Eric P Zorrilla, Glenn R Valdez, Joachim Nozulak, George F Koob, Athina Markou

Institutions: Scripps Research Institute, Novartis (Switzerland)

Language: English

Topic: Neuropeptides and Animal Physiology

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G2229086814, ROLE OF CORTICOTROPIN RELEASING FACTOR IN ETHANOL WITHDR, G454966702, Biology of Neuroendocrine Peptides

OpenAlex ID: W2007977295

FWCI: 3.863

Cites: 105

Cited by: 159

Related to: 10